Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie M Vose

Showing results (231-240 of 299) with videos related to

Pageof 30
Sort By:
Blood Advances|December 5, 2023
Bridging therapy with axicabtagene ciloleucel for large B-cell lymphoma: results from the US Lymphoma CAR-T ConsortiumMichael D Jain, Miriam T Jacobs, Feng Gao, et al.
Blood|November 6, 2020
Outcomes of patients with large B-cell lymphoma progressing after axicabtagene ciloleucel therapyJay Y Spiegel, Saurabh Dahiya, Michael D Jain, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2021
Genome-Wide miRNA Expression Profiling of Molecular Subgroups of Peripheral T-cell LymphomaWaseem Lone, Alyssa Bouska, Sunandini Sharma, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 30, 2004
Autologous transplantation for diffuse aggressive non-Hodgkin lymphoma in first relapse or second remissionJulie M Vose, Douglas J Rizzo, Jing Tao-Wu, et al.
Blood|April 12, 2012
Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosisJaveed Iqbal, Yulei Shen, Yanyan Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 8, 2006
Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphomaTimothy C Greiner, Chiranjib Dasgupta, Vincent V Ho, et al.
Blood|September 26, 2012
Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity?Ulrike Bacher, Evgeny Klyuchnikov, Jennifer Le-Rademacher, et al.
Bone Marrow Transplantation|January 4, 2024
Long-term outcomes of patients with large B-cell lymphoma treated with axicabtagene ciloleucel and prophylactic corticosteroidsOlalekan O Oluwole, Edouard Forcade, Javier Muñoz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2009
A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracyWilliam W L Choi, Dennis D Weisenburger, Timothy C Greiner, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 2, 2006
Non-Hodgkin's lymphoma. Clinical practice guidelines in oncologyAndrew D Zelenetz, Ranjana H Advani, Francis Buadi, et al.
Pageof 30

Showing results (231-240 of 299) with videos related to

Sort By:
Pageof 30
Blood Advances|December 5, 2023
Bridging therapy with axicabtagene ciloleucel for large B-cell lymphoma: results from the US Lymphoma CAR-T ConsortiumMichael D Jain, Miriam T Jacobs, Feng Gao, et al.
Blood|November 6, 2020
Outcomes of patients with large B-cell lymphoma progressing after axicabtagene ciloleucel therapyJay Y Spiegel, Saurabh Dahiya, Michael D Jain, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2021
Genome-Wide miRNA Expression Profiling of Molecular Subgroups of Peripheral T-cell LymphomaWaseem Lone, Alyssa Bouska, Sunandini Sharma, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 30, 2004
Autologous transplantation for diffuse aggressive non-Hodgkin lymphoma in first relapse or second remissionJulie M Vose, Douglas J Rizzo, Jing Tao-Wu, et al.
Blood|April 12, 2012
Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosisJaveed Iqbal, Yulei Shen, Yanyan Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 8, 2006
Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphomaTimothy C Greiner, Chiranjib Dasgupta, Vincent V Ho, et al.
Blood|September 26, 2012
Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity?Ulrike Bacher, Evgeny Klyuchnikov, Jennifer Le-Rademacher, et al.
Bone Marrow Transplantation|January 4, 2024
Long-term outcomes of patients with large B-cell lymphoma treated with axicabtagene ciloleucel and prophylactic corticosteroidsOlalekan O Oluwole, Edouard Forcade, Javier Muñoz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2009
A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracyWilliam W L Choi, Dennis D Weisenburger, Timothy C Greiner, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 2, 2006
Non-Hodgkin's lymphoma. Clinical practice guidelines in oncologyAndrew D Zelenetz, Ranjana H Advani, Francis Buadi, et al.
Pageof 30